Modulation of excitatory amino acids pathway: A possible therapeutic approach to chronic daily headache associated with analgesic drugs abuse

International Journal of Clinical Pharmacology Research

Volumn 17, Issue 2-3, 1997, Pages 97-100

  Nicolodi, M ^a,b   Del Bianco, P L ^a   Sicuteri, F ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Interuniv Ctr Neurochem Clin P   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; EXCITATORY AMINO ACID; GABAPENTIN; KETAMINE; LAMOTRIGINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADULT; ANALGESIC AGENT ABUSE; ANXIETY NEUROSIS; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUNKENNESS; FEMALE; FOLLOW UP; HEADACHE; HUMAN; HYPERALGESIA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ACETIC ACIDS; ADULT; AMINES; CHRONIC DISEASE; CYCLOHEXANECARBOXYLIC ACIDS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; KETAMINE; MALE; MIDDLE AGED; MIGRAINE DISORDERS; OPIOID-RELATED DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME; TRIAZINES;

EID: 0031371415     PISSN: 02511649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Nicolodi M., Coppola G., Sicuteri R., Sicuteri F. Viscerai pain heritability in migraineurs blood akins. IASP 7th World Congress on Pain. August 22-27, Paris, 1993, p. 12.
2. Nicolodi M. et al. Visceral pain threshold is deeply lowered far from the head in migraine. Headache, 34, 12-19, 1994.
3. Nicolodi M., Sicuteri F. Hyperalgesia and over-reaction in migraine as signs of central pain. In: Clifford-Rose F., ed. 'Advances in headache research: 3′, Smith-Gordon. London. 1994, pp. 45-47.
4. Rice A.S.C., McMahon S.B. Pre-emptive intrathecal administration of an NMDA receptor antagonist (AP-S) prevents hyper-reflexia in a model of persistent visceral pain. Pain, 57 335-340, 1994.
5. Woolf C.J.,Thompson S.W. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic-acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain, 44, 293-299, 1991.
6. Malenka R.C. The role of post-synaptic calcium in the induction of long-term potentiation. Mol. Neurobiol. 5, 289-295, 1992.
7. Higgins G.A., Nguyen P., Sellers E.M. The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal. Life Sci., 50, 167-172. 1992.
8. Church J., Lodge D. N-methyl-D-aspartate (NMDA) antagonism is central to the actions of ketamine and other phencyclidine receptor ligands. In: Domno E.F., ed. 'Status of ketamine in anesthesiology'. NPP Books, Ann Arbor, MI, 1990, pp. 501-519
9. Levy R.H., Mattson R.H., Meldrum B.S. (Eds), 'Antiepilectic drugs', Fourth edition. Lippincott-Raven, Philadelphia, 1995.
10. Leach M.J., Baxter M.G., Critcheley M.A.E. Neurochemical and behavioral aspects of lamotrigine. Epilepsia, 32 (Suppl. 2), S4-S8, 1991.
11. Headache Classification Committee of the International Headache Society Classification and diagnostic criteria for headache disorders, cranialneuralgias and facial pain. Cephalalgia, 8 (Suppl. 7), 1-96, 1988.
12. Wang R.I.H., Wiesen R.L., Treul S., Stockdale S. A brief anxiety rating scale in evaluation of anxiolitics. J. Clin. Pharmacol., 6, 99-105, 1976.
13. Zung W.W. A self-rating depression scale. Arch. Gen. Psychiatry, 2, 63-70, 1965.
14. Fowler R.S. Simple non-language test of new learning. Perceptual and Motor Skills, 29, 895-901, 1969.